Physician profile
Aniruddh Setya
NPI 1588914857
$1,129.09
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $354 · 2022: $514 · 2023: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $244.57 | 2022 | |
| Janssen Biotech, INC. | $242.72 | 2021-2023 | Remicade, Simponi Aria, Stelara |
| Abbvie INC. | $210.69 | 2021-2022 | |
| Qol Medical, LLC | $137.95 | 2021-2023 | Sucraid |
| Regeneron Healthcare Solutions, INC. | $80.51 | 2022-2023 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $69.50 | 2021-2023 | Gattex |
| Genzyme Corporation | $48.27 | 2022 | |
| Travere Therapeutics, INC. | $25.87 | 2023 | Cholbam |
| Mirum Pharmaceuticals, INC. | $24.72 | 2023 | Livmarli |
| Amgen INC. | $24.31 | 2023 | Amjevita, Avsola |
| Albireo Pharma, INC. | $19.98 | 2023 | Bylvay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aniruddh Setya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.